Domov › Crohnova bolezen › Rhode Island › Providence

Klinične študije za Crohnova bolezen v Providence, RI

12 študij za Crohnova bolezen išče udeležence na lokacijah v Providence in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Vključevanje udeležencevFaza 3

University Gastroenterology - Providence - West River Street ( Site 5057), Providence

Starost 16–80 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06430801

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Vključevanje udeležencevFaza 2

University Gastroenterology - Providence - Staniford Street /ID# 280919, Providence

Starost 18–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07697456

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

Vključevanje udeležencevFaza 4

University Gastroenterology, Providence

Starost 18–80 · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT06581328

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

Vključevanje udeležencevFaza 2/3

University Gastroenterology, Providence

Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07196722

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

Vključevanje udeležencevFaza 2

University Gastroenterology Providence, Providence

Starost 18–75 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06233461

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Vključevanje udeležencevFaza 3

University Gastroenterology, Providence

Starost 18–70 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT06937099

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Vključevanje udeležencevFaza 3

University Gastroenterology-Site Number: 8400103, Providence

Starost 16–80 · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT07184931

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Vključevanje udeležencevFaza 3

University Gastroenterology - GI Alliance-Site Number: 8400103, Providence

Starost 16–80 · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT07184944

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Vključevanje udeležencevFaza 4

University Gastroenterology, Providence

Starost 18–70 · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT06045754

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

Vključevanje udeležencev

Gastroenterology Associates, Providence

Starost 18 in več · Vsi spoli · Posodobljeno 7. avg. 2026 · NCT05230173

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

Vključevanje udeležencevFaza 4

Rhode Island Hospital, Providence

Starost 6–17 · Vsi spoli · Posodobljeno 27. maj 2026 · NCT05781152

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Vključevanje udeležencevFaza 2

Mirador Therapeutics Selected Site, Providence

Starost 18–80 · Vsi spoli · Posodobljeno 12. mar. 2026 · NCT07113522

Študije za Crohnova bolezen v drugih mestih

Druge študije v Providence

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.